Legal Representation
Attorney
Jodi A. DeSchane
USPTO Deadlines
Next Deadline
945 days remaining
Section 8 & 9 Renewal Due (Principal Register) (Based on registration date 20180731)
Due Date
July 31, 2028
Grace Period Ends
January 31, 2029
Application History
32 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 27, 2024 | NA85 | E | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | Loading... |
| Dec 27, 2024 | C15P | O | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | Loading... |
| Dec 27, 2024 | APRE | A | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | Loading... |
| Jul 29, 2024 | E815 | I | TEAS SECTION 8 & 15 RECEIVED | Loading... |
| Jul 31, 2023 | REM1 | E | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | Loading... |
| Jan 3, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Jan 3, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Jan 3, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Jan 3, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Jan 3, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jul 31, 2018 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| May 15, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| May 15, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Apr 25, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Apr 5, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 30, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 29, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 29, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jan 19, 2018 | GEAN | O | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jan 19, 2018 | GEAP | O | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | Loading... |
| Jan 19, 2018 | EPEN | O | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY | Loading... |
| Jan 19, 2018 | CPEA | R | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | Loading... |
| Dec 30, 2017 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Dec 30, 2017 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Dec 30, 2017 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Dec 15, 2017 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Dec 12, 2017 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Dec 12, 2017 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Dec 12, 2017 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Dec 4, 2017 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Sep 6, 2017 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Sep 1, 2017 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Hyaluronic acid and the sodium salt therefrom, namely, sodium hyaluronate, sold as a raw chemical for use in manufacturing processes, namely, for use in compounding pharmaceuticals or cosmetics
First Use Anywhere:
Nov 11, 1986
First Use in Commerce:
Nov 11, 1986
Class 005
[ Pharmaceutical preparations containing hyaluronic acid, sodium hyaluronate, or a derivative of hyaluronic acid for use in eye surgery, repair of flexible tissue, and injectable drug delivery compounds used as a facilitating agent for other pharmaceuticals ]
First Use Anywhere:
19830700
First Use in Commerce:
19830700
Class 035
regulatory submission management, namely, assisting others in preparing documents and information for their filing of applications for new drugs and medical devices with governmental regulatory bodies
First Use Anywhere:
Jan 16, 1998
First Use in Commerce:
Jan 16, 1998
Class 039
packaging of custom designed and manufactured pharmaceuticals for others, namely, filling syringes, vials and bags, labeling, pouching, and traying
First Use Anywhere:
Jan 16, 1998
First Use in Commerce:
Jan 16, 1998
Class 040
contract manufacturing in the field of fermentation services for microbial and yeast fermentation; custom formulation of pharmaceuticals
First Use Anywhere:
Jan 16, 1998
First Use in Commerce:
Jan 16, 1998
Class 042
designing and developing pharmaceuticals; inspection of custom designed and manufactured pharmaceuticals
First Use Anywhere:
Jan 16, 1998
First Use in Commerce:
Jan 16, 1998
Class 045
regulatory compliance consulting in the field of pharmaceuticals and medical devices
First Use Anywhere:
Jan 16, 1998
First Use in Commerce:
Jan 16, 1998
Additional Information
Pseudo Mark
LIFE CORE BIOMEDICAL
Classification
International Classes
001
005
035
039
040
042
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOMEDICAL"